India's Suven Pharma rallies to over 1.5-yr high
** Suven Pharmaceuticals SUVH.NS shares 3.6% to 615
rupees, their highest since April 29, 2022
** Stock set for fourth straight day of gains, during which
it has risen nearly 6%
** Stock has now gained 8.4% since the company posted
results on Nov. 9
** Since then, the stock has also traded above its 50- ,100-
and 200-day daily moving averages
** More than 380,000 shares traded by 1.28 p.m. IST, 1.4x
the 30-day avg
** Stock up nearly 22% YTD, set for its best on-year gain
since listing
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees